Study of the critical points and the role of the pores and viscosity in carbamazepine hydrophilic matrix tablets

被引:21
作者
Aguilar-de-Leyva, Angela [1 ]
Cifuentes, Celia [1 ]
Rajabi-Siahboomi, Ali R. [2 ]
Caraballo, Isidoro [1 ]
机构
[1] Univ Seville, Dept Pharm & Pharmaceut Technol, E-41012 Seville, Spain
[2] Colorcon Inc, Global Headquarters, Harleysville, PA USA
关键词
Hydroxypropylmethyl cellulose; Hydrophilic matrices; Carbamazepine; Tablet porosity; Percolation threshold extended release; CONTROLLED DRUG-DELIVERY; PERCOLATION THEORY; PARTICLE-SIZE; SOLUTE RELEASE; HPMC; SYSTEMS; THRESHOLDS; MECHANISMS; DIFFUSION; RATIO;
D O I
10.1016/j.ejpb.2011.09.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Percolation theory has been applied to estimate the Hypromellose (HPMC) percolation thresholds and the influence of the polymer viscosity and the initial porosity on these thresholds in carbamazepine multicomponent matrix formulations. Different batches containing two viscosity grades of HPMC as hydrophilic matrix forming polymer. MCC and lactose as fillers, and a lubricant mixture have been manufactured varying the compression pressure in order to obtain matrices with three levels of initial porosity. The results suggested the existence of an excipient percolation threshold between 13 and 15% v/v of HPMC for the different batches prepared. It has been found that the percolation threshold for this polymer is independent on the formulation factors studied in this paper: polymer viscosity and initial porosity of the matrices. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:136 / 142
页数:7
相关论文
共 35 条
  • [1] [Anonymous], 1996, PHARM ACTA HELV, DOI [10.1016/S0031-6865(96)00023-4, DOI 10.1016/S0031-6865(96)00023-4]
  • [2] [Anonymous], ACTA FARM BONAERENSE
  • [3] PERCOLATION THEORY AND COMPACTIBILITY OF BINARY POWDER SYSTEMS
    BLATTNER, D
    KOLB, M
    LEUENBERGER, H
    [J]. PHARMACEUTICAL RESEARCH, 1990, 7 (02) : 113 - 117
  • [4] Bonny J., 1993, Pharmaceutica Acta Helvetiae, V68, P25, DOI DOI 10.1016/0031-6865(93)90005-Q
  • [5] BONNY JD, 1991, PHARM ACTA HELV, V66, P160
  • [6] PERCOLATION THEORY - APPLICATION TO THE STUDY OF THE RELEASE BEHAVIOR FROM INERT MATRIX SYSTEMS
    CARABALLO, I
    FERNANDEZAREVALO, M
    HOLGADO, MA
    RABASCO, AM
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 96 (1-3) : 175 - 181
  • [7] Relationship between drug percolation threshold and particle size in matrix tablets
    Caraballo, I
    Millan, M
    Rabasco, AM
    [J]. PHARMACEUTICAL RESEARCH, 1996, 13 (03) : 387 - 390
  • [8] Study of percolation thresholds in ternary tablets
    Caraballo, I
    FernandezArevalo, M
    Millan, M
    Rabasco, AM
    Leuenberger, H
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 139 (1-2) : 177 - 186
  • [9] Factors affecting drug release from hydroxypropyl methylcellulose matrix systems in the light of classical and percolation theories
    Caraballo, Isidoro
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2010, 7 (11) : 1291 - 1301
  • [10] Castellanos-Gil E., 2008, PHARM MANUFACTURING, P977